Dutch ingredients group DSM saw earnings climb in the first half of the year, driven by acquisitions and growth in its nutrition business.
In the six months to the end of June earnings reached EUR231m (US$306m), a 24.2% increase on a year earlier. Its acquisitions of nutritional supplements company Tortuga in Latin America and New Zealand nutritional products firm Unitech Industries boosted growth, in addition to a 20% jump in EBITDA in DSM’s nutrition business.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Operating profit was up 23.1% at EUR340m, while net sales climbed 6.1% to EUR4.84bn.
For the remainder of the year, DSM said it will continue to focus on operational performance and the integration of its acquisitions and expects “strong” EBITDA growth in 2013, moving towards EUR1.4bn.
Click here to view the full earnings release.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
